Chattem’s Xyzal Allergy 24HR Launches to OTC Market
March 30 2017 - 6:00AM
Business Wire
- After obtaining FDA approval in
February 2017, Xyzal Allergy 24 HR launches to over-the-counter
market.
- MPS and Chattem together engineer brand
new design and structure of bespoke Xyzal package tailored to
consumer market.
- Two million windowed Xyzal cartons
produced and delivered from two qualified MPS facilities to support
the launch within a short time frame.
Multi Packaging Solutions (“MPS”), a global leader in
value-added print and packaging solutions for the healthcare,
branded consumer and multi-media markets, has brought agility to
the consumer launch of Chattem’s Xyzal Allergy 24HR, delivering two
million windowed cartons from two MPS facilities in short order –
just in time for allergy season.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170330005058/en/
After obtaining FDA approval in February
2017, Xyzal Allergy 24 HR launches to over-the-counter market.
(Photo: Business Wire)
Until recently, Xyzal, an antihistamine, was previously
available only as a prescription medication. In February 2017,
Chattem, a company of Sanofi, announced that the FDA had approved
its 24-hour formulation of levocetirizine dihydrochloride (Xyzal
Allergy 24HR) for OTC treatment of symptoms associated with
seasonal and year-round allergies.
Commenting on the news in a recent company press release, Robert
Long, Sanofi’s Head of North America Consumer Healthcare, notes,
“The FDA approval of Xyzal builds on our heritage of successful
Rx-to-OTC switches, and adds another trusted option to our existing
portfolio of OTC allergy medications…we look forward to making it
available to allergy sufferers across the country, as the latest
product in our growing consumer healthcare business.”
The challenge of bringing Xyzal to consumers and pharmacy
shelves was complex for a number of reasons. Firstly, Chattem
sought to make the product viewable to the consumer by
incorporating a window into the design of the carton. The package
was to include a literature insert as well as discreet 100%
application of checkpoint and sensormatic security tags. In
addition to the project’s unique structure specifications, the
launch plan also demanded seamless production and delivery of two
million cartons five days after FDA approval had been granted.
MPS worked with Chattem to develop several designs for the
carton structure that achieved their requirements. After choosing a
suitable design, the client proceeded to qualify two MPS facilities
to produce the cartons, MPS Indianapolis and MPS Dallas. Careful
quality control measures - including specification management and
process control – enabled both facilities to maintain a consistent
supply. Among the quality control measures implemented was the
adoption of a new glue detection process utilizing state-of-the-art
equipment.
Travis McDonough, MPS SVP of Quality, notes, “The compressed
time frame for this launch dictated that we run the job in two
facilities. MPS was able to engineer something that really worked
structure wise, perform exhaustive line tests, and ensured
consistent performance in a machine filled environment. This
project speaks volumes about MPS’s ability to respond to client
needs in a consistent fashion even when multiple plants are
involved.”
Within a short time frame, MPS had produced two million cartons
to support Chattem’s Xyzal launch. The packages were printed and
die cut in MPS Indianapolis while the windowing, folding and gluing
was produced in both MPS Indianapolis and MPS Dallas. This March,
Xyzal will make it’s debut and grace the shelves of major
pharmacies across the country.
Pat Borders, MPS Account Executive for Chattem, comments on the
project, “This launch was critical for Chattem, and I’m pleased
that we were able to deliver above and beyond their expectations.
The Xyzal package is a great example of how our team collaborates
to make creative and structural concepts a commercial success.”
About Multi Packaging Solutions
MPS is a leading global provider of value-added packaging
solutions to a diverse customer base across the healthcare,
consumer and multi-media markets. MPS provides its customers with
an extensive array of print-based specialty packaging solutions,
including premium folding cartons, inserts, labels and rigid
packaging across a variety of substrates and finishes. MPS has over
60 manufacturing locations across North America, Europe and Asia
and employs approximately 8,800 people.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170330005058/en/
Multi Packaging
SolutionsEurope & AsiaBob Houghton,
+44 1635 290521Marketing
CommunicationsBob.Houghton@multipkg.comorNorth AmericaCal
Branagan, +1-646-834 1527Marketing
CommunicationsCal.Branagan@multipkg.com
MULTI PACKAGING SOLUTIONS INTERN (NYSE:MPSX)
Historical Stock Chart
From Jun 2024 to Jul 2024
MULTI PACKAGING SOLUTIONS INTERN (NYSE:MPSX)
Historical Stock Chart
From Jul 2023 to Jul 2024